Invitrogen™ Human BCAR3 Synthetic Peptide

Catalog No.	Quantity
PEP1467	50 μg

Catalog No. PEP1467 Supplier Invitrogen™ Supplier No. PEP1467

Description

Synthetic Peptide

BCAR3 Synthetic Peptide, PEP-1467, from Invitrogen.

Breast tumors are initially dependent on estrogens for growth and progression and can be inhibited by anti-estrogens such as tamoxifen. However, breast cancers progress to become anti-estrogen resistant. Breast cancer anti-estrogen resistance gene 3 was identified in the search for genes involved in the development of estrogen resistance. The gene encodes a component of intracellular signal transduction that causes estrogen-independent proliferation in human breast cancer cells. The protein contains a putative src homology 2 (SH2) domain, a hall mark of cellular tyrosine kinase signaling molecules, and is partly homologous to the cell division cycle protein CDC48.

Specifications

• Gene ID (Entrez): 8412
• Species: Human
• Purification Method: purified
• Accession Number: O75815
• Common Name: Human BCAR3
• Concentration: 200 μg/mL
• Content And Storage: -20°C
• Description: Synthetic Peptide
• Format: Liquid
• Formulation: PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
• For Use With (Application): Blocking Assay, Control
• Gene Symbol: BCAR3
• Lyophilized: No
• Preservative: 0.02% sodium azide
• Product Type: Peptide
• Quantity: 50 μg
• Regulatory Status: RUO - research use only
• Storage Buffer: PBS